Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecromeximab in advanced stage IV melanoma
NCT00199342Phase 2Terminated
- Sponsor
- Kyowa Kirin
- Start
- Nov 2004
- Primary completion
- Oct 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ecromeximab in melanoma, sponsored by Kyowa Kirin. Started Nov 2004; status: terminated.
02
Drugs
ecromeximab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00199342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199342.